Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

Clinical trial NCT00101816 · COMPLETED

Trial details

NCT number: NCT00101816
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Myeloid Leukemia Blast Crisis

Start date: 2004-12-01
Primary completion: 2006-08-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.